SNOA Sonoma Pharmaceuticals Inc.: יחס שווי שוק לשווי בספרים

Sonoma Pharmaceuticals is recognized as the global benchmark for safety in the production of hypochlorous acid-based products. Diversification through supplies to pharmacies and clinics minimizes risks within dermatology. The medtech business focuses on the B2B segment, creating gentle solutions for oral and skin care. The company's current P/B ratio on this chart clearly demonstrates the market value of its assets, while the 0.80 indicator confirms the current level.

The ratio of market value to net assets determines the business premium over its book value. This coefficient allows for an assessment of the risk of capital loss during a sharp decline in quotes. By analyzing changes in the price-to-book multiple, an investor identifies the stability of the market valuation. For Sonoma Pharmaceuticals (SNOA), this indicator confirms the fundamental base. Stable demand for antiseptics minimizes asset volatility even during periods of macroeconomic shocks.